MarketsSingle-source
2.1
Dextech reports increased operating loss for Q4 2025/26 fiscal year
Dagens IndustriLO·SE·about 1 hour ago
Nanologica's Q1 2026 financial results show an increase in operating losses to 18.1 million SEK, compared to 11.3 million SEK in the prior period. While the company reported a revenue boost, the widening loss highlights ongoing operational cost pressures.